"0173-0846-08" National Drug Code (NDC)

NDC Code	0173-0846-08
Package Description	120 CAPSULE in 1 BOTTLE (0173-0846-08)
Product NDC	0173-0846
Product Type Name	HUMAN PRESCRIPTION DRUG
Proprietary Name	Tafinlar
Non-Proprietary Name	Dabrafenib
Dosage Form	CAPSULE
Usage	ORAL
Start Marketing Date	20130610
End Marketing Date	20180831
Marketing Category Name	NDA
Application Number	NDA202806
Manufacturer	GlaxoSmithKline LLC
Substance Name	DABRAFENIB MESYLATE
Strength	50
Strength Unit	mg/1
Pharmacy Classes	Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C8 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Organic Anion Transporter 1 Inhibitors [MoA],Organic Anion Transporter 3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA]